is compounded semaglutide going away GLP-1 ban: What providers need to know FDA is moving to restrict
Description
Some patients find that anxiety on GLP-1 reflects undiagnosed or undertreated underlying anxiety disorder, making concurrent psychiatric care essential
Follow the food protocol
These medications have been shown to suppress appetite, slow gastric emptying, and improve insulin sensitivity, making them a powerful tool in the fight against obesity
Reassess after significant weight loss milestones
doi: 10.1038/nrdp.2016.28
resume treatment if significant regain occurs Accept that some regain is normal and doesn't indicate failure Many individuals require ongoing medication for sustained weight loss maintenance, similar to other chronic disease treatments
